公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2011 | Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy | Hsu C.-S.; SHIH-JER HSU ; Chen H.-C.; TAI-CHUNG TSENG ; CHEN-HUA LIU ; Niu W.-F.; Jeng J.; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 56 | 54 | |
2013 | Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients | Hsu C.-S.; SHIH-JER HSU ; Chen H.-C.; CHEN-HUA LIU ; Jeng J.; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 5 | 5 | |
2009 | Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection | Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; Wang C.-C.; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 37 | 34 | |
2010 | Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection | Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; SHIH-JER HSU ; CHI-LING CHEN ; HWANG, JUEY-JEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 30 | 30 | |
2007 | Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma | Lin C.-L.; CHEN-HUA LIU ; Chen W.; Huang W.-L.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 78 | 74 | |
2008 | Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma | Yang H.-I.; Shiou-Hwei Yeh ; PEI-JER CHEN ; Iloeje U.H.; Jen C.-L.; Su J.; Wang L.-Y.; Lu S.-N.; You S.-L.; DING-SHINN CHEN ; Liaw Y.-F.; Chen C.-J.; REVEAL-HBV Study Group; CHYI-FENG JAN | Journal of the National Cancer Institute | 524 | 453 | |
2021 | Autophagy restricts mitochondrial DNA damage-induced release of ENDOG (endonuclease G) to regulate genome stability | Chao T.; Shih H.-T.; Hsu S.-C.; PEI-JER CHEN ; Fan Y.-S.; YUNG-MING JENG ; Shen Z.-Q.; Tsai T.-F.; ZEE-FEN CHANG | Autophagy | 19 | 14 | |
1999 | Bacterial infections associated with hepatic arteriography and transarterial embolization for hepatocellular carcinoma: A prospective study | Chen C.; Tsang Y.-M.; PO-REN HSUEH ; GUAN-TARN HUANG ; PEI-MING YANG ; JIN-CHUAN SHEU ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN | Clinical Infectious Diseases | 31 | 21 | |
2003 | Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Gastroenterology | 491 | 437 | |
2005 | Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B | Lin C.-L.; Liao L.-Y.; Wang C.-S.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Liver International | 72 | 64 | |
2019 | Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level | HO-SHENG CHEN ; JIA-FENG WU ; TUNG-HUNG SU ; HUEY-LING CHEN ; HONG-YUAN HSU ; Xia N.-S.; PEI-JER CHEN ; MEI-HWEI CHANG | Hepatology | 16 | 9 | |
2020 | Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy | TAI-CHUNG TSENG ; Peng C.-Y; Hsu Y.-C; TUNG-HUNG SU ; Wang C.-C; CHUN-JEN LIU ; HUNG-CHIH YANG ; Yang W.-T; Lin C.-H; Yu M.-L; Lai H.-C; Tanaka Y; Nguyen M.H; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Liver Cancer | 17 | 13 | |
1997 | Benign recurrent intrahepatic cholestasis | CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; TSUI-LIEN MAO ; Wang T.-H.; DING-SHINN CHEN | Journal of the Formosan Medical Association | 1 | 0 | |
2012 | Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity | Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN ; Kim I.; Shiau C.-W. | European Journal of Medicinal Chemistry | 72 | 70 | |
1997 | Blood-bank screening for hepatitis G [14] | JIA-HORNG KAO ; PEI-JER CHEN ; JIN-TOWN WANG ; Lai M.-Y.; DING-SHINN CHEN | Lancet | 7 | 5 | |
2018 | Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan | Hsieh M.-H.; Yeh M.-L.; TUNG-HUNG SU ; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; CHUN-JEN LIU ; Yu M.-L. | Journal of the Formosan Medical Association | 5 | 4 | |
2024 | Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B | Cheng, Pin-Nan; Feng, I-Cher; Chen, Jyh-Jou; Kuo, Hsing-Tao; Lee, Pei-Lun; Yu, Ming-Lung; Chiu, Yen-Cheng; Chiu, Hung-Chih; Chien, Shih-Chieh; PEI-JER CHEN ; CHUN-JEN LIU | Alimentary pharmacology & therapeutics | 2 | 0 | |
2009 | Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway | Chen K.-F.; Yeh P.-Y.; CHIUN HSU ; CHIH-HUNG HSU ; YEN-SHEN LU ; Hsieh H.-P.; PEI-JER CHEN ; ANN-LII CHENG | Journal of Biological Chemistry | 89 | 84 | |
2011 | Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A | Chen K.-F.; Yu H.-C.; Liu C.-Y.; Chen H.-J.; Chen Y.-C.; Hou D.-R.; PEI-JER CHEN ; ANN-LII CHENG | Molecular Cancer Therapeutics | 36 | 32 | |
1998 | Brief communication: Efficacy of ribavirin plus interferon α on viraemia of GB virus-C/hepatitis G virus: Comparison with interferon α alone | JIA-HORNG KAO ; Lai M.-Y.; Chen W.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 10 | 10 | |